New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

BackgroundPrimary aldosteronism (PA) is a common cause of secondary hypertension and associated with higher incidence of new-onset atrial fibrillation (NOAF). However, the effects of surgical or medical therapies on preventing NOAF in PA patents remain unclear. The aim of this meta-analysis study wa...

Full description

Bibliographic Details
Main Authors:	Cheng-Hsuan Tsai, Ya-Li Chen, Chien-Ting Pan, Yen-Tin Lin, Po-Chin Lee, Yu-Wei Chiu, Che-Wei Liao, Zheng-Wei Chen, Chin-Chen Chang, Yi-Yao Chang, Chi-Sheng Hung, Yen-Hung Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Endocrinology
Subjects:	hyperaldosteronism primary aldosteronism adrenalectomy mineralocorticoid receptor antagonist atrial fibrillation
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.646933/full

Similar Items

Influence of Different Treatment Strategies on New‐Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort‐Based Study
by: Chien‐Ting Pan, et al.
Published: (2020-03-01)

Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
by: Wei-Chieh Huang, et al.
Published: (2021-05-01)

Adverse Effects of Aldosterone: Beyond Blood Pressure
by: Jenifer M. Brown
Published: (2024-04-01)

Influence of autonomous cortisol secretion in patients with primary aldosteronism: subtype analysis and postoperative outcome
by: Kuang Hung, et al.
Published: (2023-11-01)

Strategies for subtyping primary aldosteronism
by: Yun-Hsuan Yang, et al.
Published: (2024-03-01)

Molecular Mechanisms of Primary Aldosteronism
by: Sergei G. Tevosian, et al.
Published: (2019-12-01)

Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism
by: Sumaiya Ahmed, et al.
Published: (2022-04-01)

Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism
by: Tomomi Ueda, et al.
Published: (2022-07-01)

Editorial: Expanding spectrum of primary aldosteronism: exploring new grounds
by: Norlela Sukor, et al.
Published: (2023-04-01)

Aldosterone and the heart: still an unresolved issue?
by: Cristiana eCatena, et al.
Published: (2014-10-01)

Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism
by: Chien-Wei Huang, et al.
Published: (2020-07-01)

Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score–Matching Follow‐Up Study With Tissue Doppler Imaging
by: Yi‐Yao Chang, et al.
Published: (2019-11-01)

Hyperglycemia Potentiates Prothrombotic Effect of Aldosterone in a Rat Arterial Thrombosis Model
by: Anna Gromotowicz-Poplawska, et al.
Published: (2021-02-01)

Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
by: Yu-Fang Lin, et al.
Published: (2020-12-01)

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism
by: Chung-Yi Cheng, et al.
Published: (2021-12-01)

Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age
by: Seung Hun Lee, et al.
Published: (2021-04-01)

Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism
by: Yu-Cheng Lu, et al.
Published: (2023-05-01)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01)

Primary Aldosteronism and Pregnancy
by: Tomáš Zelinka, et al.
Published: (2020-02-01)

Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism
by: Chi-Shin Tseng, et al.
Published: (2024-03-01)

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
by: Xurong Mai, et al.
Published: (2022-11-01)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
by: Wei‐Chieh Huang, et al.
Published: (2019-12-01)

A Prospective Comparative Study on Cardiac Alterations After Surgery and Drug Treatment of Primary Aldosteronism
by: Yi-Lin Chen, et al.
Published: (2021-11-01)

Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
by: Kentaro Okamoto, et al.
Published: (2021-04-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

<i>KCNJ5</i> Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness
by: Yi-Yao Chang, et al.
Published: (2021-08-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

The role of aldosterone in the pathogenesis of diabetic retinopathy
by: Kangcheng Liu, et al.
Published: (2023-04-01)

Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma
by: Chen Fang, et al.
Published: (2023-11-01)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
by: Marisa K. Ames, et al.
Published: (2022-11-01)

Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism
by: Chien-Ting Pan, et al.
Published: (2021-04-01)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
by: Luo Shi, et al.
Published: (2019-11-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
by: Lukas Engler, et al.
Published: (2019-04-01)

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
by: Qingming Ding, et al.
Published: (2022-10-01)

Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism
by: Jung Hee Kim, et al.
Published: (2022-04-01)

Aldosterone: Essential for Life but Damaging to the Vascular Endothelium
by: Michael Crompton, et al.
Published: (2023-06-01)

C-Arm Computed Tomography-Assisted Adrenal Venous Sampling Improved Right Adrenal Vein Cannulation and Sampling Quality in Primary Aldosteronism
by: Chung Hyun Park, et al.
Published: (2018-05-01)

Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01)

Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015
by: Yu F Osmolovskaya, et al.
Published: (2015-09-01)